Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-02 | NovoCure Ltd | Paravasthu Mukund
(Chief Operating Officer) |
S | Ordinary Shares | D | 44 | $16.69 - $16.69 | $734 |
| 2024-11-04 | NovoCure Ltd | Paravasthu Mukund
(Chief Operating Officer) |
A | Ordinary Shares | A | 30138 | $0.00 - $0.00 | $0 |
| 2024-06-28 | NovoCure Ltd | Cordova Ashley
(Chief Financial Officer) |
A | Ordinary Shares | A | 1286 | $12.24 - $12.24 | $15,740 |
| 2024-06-28 | NovoCure Ltd | Leonard Frank X
(EVP, Pres., Novocure Oncology) |
A | Ordinary Shares | A | 1736 | $12.24 - $12.24 | $21,248 |
| 2024-06-28 | NovoCure Ltd | Puri Michal Nath
(Chief Human Resources Officer) |
A | Ordinary Shares | A | 1736 | $12.24 - $12.24 | $21,248 |
| 2024-08-02 | NovoCure Ltd | Cordova Ashley
(Chief Financial Officer) |
S | Ordinary Shares | D | 688 | $20.14 - $20.14 | $13,857 |
| 2024-06-05 | NovoCure Ltd | Ocean Allyson J
(Director) |
A | Restricted Stock Units | A | 4053 | $0.00 - $0.00 | $0 |
| 2024-06-05 | NovoCure Ltd | Madden Martin J.
(Director) |
A | Ordinary Shares | A | 4053 | $0.00 - $0.00 | $0 |
| 2024-06-05 | NovoCure Ltd | Hung David
(Director) |
A | Restricted Stock Units | A | 4053 | $0.00 - $0.00 | $0 |
| 2024-06-05 | NovoCure Ltd | Stafford Kristin
(Director) |
A | Ordinary Shares | A | 4053 | $0.00 - $0.00 | $0 |
| 2024-06-04 | NovoCure Ltd | VERNON W ANTHONY
(Director) |
S | Ordinary Shares | D | 964 | $23.89 - $23.89 | $23,032 |
| 2024-06-05 | NovoCure Ltd | VERNON W ANTHONY
(Director) |
A | Restricted Stock Units | A | 4053 | $0.00 - $0.00 | $0 |
| 2024-06-04 | NovoCure Ltd | Scannell Timothy J
(Director) |
S | Ordinary Shares | D | 964 | $23.89 - $23.89 | $23,027 |
| 2024-06-05 | NovoCure Ltd | Scannell Timothy J
(Director) |
A | Restricted Stock Units | A | 4053 | $0.00 - $0.00 | $0 |
| 2024-06-04 | NovoCure Ltd | LEUNG GABRIEL
(Director) |
S | Ordinary Shares | D | 964 | $23.89 - $23.89 | $23,025 |
| 2024-06-05 | NovoCure Ltd | LEUNG GABRIEL
(Director) |
A | Restricted Stock Units | A | 4053 | $0.00 - $0.00 | $0 |
| 2024-06-05 | NovoCure Ltd | HILLEMAN JERYL L
(Director) |
A | Restricted Stock Units | A | 4053 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |